lisocabtagene maraleucel
bms
['lymphoma', 'transform,(-transformi),(-transforme),(-transforma),(-transforms),(-transform1),(-transform 1),(-transform-1),(-transform2),(-transform 2),(-transform-2)']
from 8am cdt, ( ) can take you through the subgroup analyses of primary refractory vs early relapsed large b-cell #lymphoma from the transform study: #crukfunded #asco23
We're here to support our broad cancer research community of 4,000 scientists and clinicians. For general Cancer Research UK news & fundraising follow @CR_UK